No improvement noted in overall or cause‐specific survival for men presenting with metastatic prostate cancer over a 20‐year period

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|6|818-823

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.6, 2014-03, pp. : 818-823

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lack of reduction in racial disparities in cancer‐specific mortality over a 20‐year period

By  

CANCER, Vol. 120, Iss. 10, 2014-05 ,pp. : 1532-1539

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response of Prostate-Specific Antigen after Androgen Withdrawal and Prognosis in Men with Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 60, Iss. 1, 1998-02 ,pp. : 28-32

Karger

Access to resources Recommend Favorite

Systemic Inflammatory Response, Prostate-Specific Antigen and Survival in Patients with Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 77, Iss. 2, 2006-08 ,pp. : 127-129

Karger

Access to resources Recommend Favorite

Prognostic Significance of Changes in Short-Term Prostate Volume and Serum Prostate-Specific Antigen after Androgen Withdrawal in Men with Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 70, Iss. 3, 2003-04 ,pp. : 195-199

Karger

Access to resources Recommend Favorite

Management and Characteristics of Patients with Metastatic Prostate Cancer in a Cohort of New Zealand Men

By  

Oncology, Vol. 88, Iss. 3, 2014-11 ,pp. : 157-163

Karger

Access to resources Recommend Favorite